T. Rowe Price Investment Management’s CME Group CME Stock Holding History

T. Rowe Price Investment Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.25M	Buy	17,759 +5,684	+47%	+$1.69M	﹤0.01%	561
2025 Q4	$3.3M	Sell	12,075 -42,884	-78%	-$11.7M	﹤0.01%	595
2025 Q3	$14.8M	Sell	54,959 -474,180	-90%	-$129M	0.01%	536
2025 Q2	$146M	Buy	529,139 +7,921	+2%	+$2.15M	0.09%	221
2025 Q1	$138M	Buy	521,218 +495,505	+1,927%	+$122M	0.09%	224
2024 Q4	$5.97M	Sell	25,713 -2,031	-7%	-$467K	﹤0.01%	571
2024 Q3	$6.12M	Sell	27,744 -564,205	-95%	-$117M	﹤0.01%	562
2024 Q2	$116M	Buy	591,949 +568,009	+2,373%	+$117M	0.07%	258
2024 Q1	$5.16M	Buy	23,940 +10,388	+77%	+$2.18M	﹤0.01%	567
2023 Q4	$2.85M	Sell	13,552 -1,005,551	-99%	-$215M	﹤0.01%	541
2023 Q3	$204M	Buy	1,019,103 +794,640	+354%	+$158M	0.14%	174
2023 Q2	$41.6M	Buy	224,463 +2,164	+1%	+$400K	0.03%	396
2023 Q1	$42.6M	Buy	+222,299	New	+$40.2M	0.03%	388

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management's CME Position: Q1 2026 in Review

T. Rowe Price Investment Management increased its CME Group (CME) stake by 47% in Q1 2026, buying an estimated $1.69M and bringing the position to 17,759 shares worth $5.25M. The position accounts for ﹤0.01% of the portfolio, ranked #561.

T. Rowe Price Investment Management first reported a position in CME in Q1 2023 and has held it in 13 quarters since. The position peaked at $204M in Q3 2023. 1,793 funds tracked by Wall St. Rank hold CME as of Q1 2026.

T. Rowe Price Investment Management held 17,759 shares of CME Group worth $5.25M as of Q1 2026.
T. Rowe Price Investment Management bought 5,684 CME Group shares in Q1 2026, an estimated $1.69M.
CME Group made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #561 holding.
T. Rowe Price Investment Management first reported a position in CME Group in Q1 2023 and has held it in 13 quarters since.
T. Rowe Price Investment Management's CME Group position peaked at $204M in Q3 2023.
1,793 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.